The purpose of this study was to examine the possible association between mortality following a hip fracture and known biochemical markers of inflammation.
The study population was identified using two local databases from Bispebjerg Hospital (Copenhagen, Denmark): the Hip Fracture Database containing all patients admitted to the hospital with a fractured hip from 1996 to 2012 and the Hip Fracture Biobank, containing whole blood, serum and plasma taken in relation to admission on a subgroup of patients from the Hip Fracture Database, consecutively collected over a period of 2.5 years from 2008 to 2011. The following biochemical markers of inflammation were included: C-reactive protein (CRP), the soluble urokinase plasminogen activating receptor (suPAR), ferritin and transferrin. The association between the blood markers and mortality was examined using Cox proportional hazards models. Hazard ratios (HR) were expressed per quartile increase in the biochemical markers.
A total of 698 patients were included, 69 (9.9%) died within 30 days after sustaining a hip fracture. The HR for 30-day mortality was significantly increased with increasing quartiles of suPAR, CRP and ferritin and with decreasing quartiles of transferrin.
This study shows that 30-day mortality after a hip fracture is associated with elevated levels of suPAR, CRP and ferritin as well as with lower levels of transferrin. This excess inflammatory response is likely caused by muscle damage associated with the hip fracture. However, this needs to be further clarified.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Abrahamsen B, van Staa T, Ariely R et al (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650
Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: Medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:1–2
Kannegaard PN, van der Mark S, Eiken P et al (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39:203–209
Norring-Agerskov D, Laulund AS, Lauritzen JB et al (2013) Metaanalysis of risk factors for mortality in patients with hip fracture. Dan Med J 60:A4675
Daugaard CL, Jorgensen HL, Riis T et al (2012) Is mortality after hip fracture associated with surgical delay or admission during weekends and public holidays? A retrospective study of 38,020 patients. Acta Orthop 83:609–613
Laulund AS, Lauritzen JB, Duus BR et al (2012) Routine blood tests as predictors of mortality in hip fracture patients. Injury 43:1014–1020
Norring-Agerskov D, Madsen CM, Abrahamsen B et al (2017) Hyperkalemia is Associated with Increased 30-Day Mortality in Hip Fracture Patients. Calcif Tissue Int 101:9–16
Madsen CM, Jantzen C, Lauritzen JB et al (2015) Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients. Osteoporos Int 27:297–404
Mosfeldt M, Pedersen OB, Riis T et al (2012) Value of routine blood tests for prediction of mortality risk in hip fracture patients. Acta Orthop 83:31–35
Kim BG, Lee YK, Park HP et al (2016) C-reactive protein is an independent predictor for 1-year mortality in elderly patients undergoing hip fracture surgery: a retrospective analysis. Medicine (Baltimore) 95:e5152
Fakler JK, Grafe A, Dinger J et al (2016) Perioperative risk factors in patients with a femoral neck fracture—influence of 25-hydroxyvitamin D and C-reactive protein on postoperative medical complications and 1-year mortality. BMC Musculoskelet Disord 17:51
Sun T, Wang X, Liu Z et al (2011) Plasma concentrations of pro- and anti-inflammatory cytokines and outcome prediction in elderly hip fracture patients. Injury 42:707–713
Forasassi C, Golmard JL, Pautas E et al (2009) Inflammation and disability as risk factors for mortality in elderly acute care patients. Arch Gerontol Geriatr 48:406–410
Kompoti M, Drimis S, Papadaki A et al (2008) Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med 19:261–265
Rallidis LS, Vikelis M, Panagiotakos DB et al (2006) Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 189:193–197
Winbeck K, Poppert H, Etgen T et al (2002) Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33:2459–2464
Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417–424
Avram MM, Fein PA, Paluch MM et al (2005) Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Adv Perit Dial 21:154–158
Ritchie RF, Palomaki GE, Neveux LM et al (1999)Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world’s literature. J Clin Lab Anal 13:280–286
Ebersole JL, Cappelli D (2000) Acute-phase reactants in infections and inflammatory diseases. Periodontol 23:19–49
Haupt TH, Kallemose T, Ladelund S et al (2014) Risk factors associated with serum levels of the Inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomark Insight 9:91–100
Eugen-Olsen J, Andersen O, Linneberg A et al (2010) Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 268:296–308
Helweg-Larsen K (2011) The Danish Register of Causes of Death. Scand J Public Health 39:26–29
Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39:30–33
Pedersen CB (2011) The Danish Civil Registration System. Scand J Public Health 39:22–25
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Petersen MB, Jørgensen HL, Hansen K et al (2006) Factors affecting postoperative mortality of patients with displaced femoral neck fracture. Injury 37:705–711
Agarwal N, Prchal JT (2009) Anemia of chronic disease (Anemia of Inflammation). Acta Haematol 122:103–108
Giannoglou GD, Chatzizisis YS, Misirli G (2007) The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med 18:90–100
Sedlář M, Kvasnička J, Krška Z et al (2015) Early and subacute inflammatory response and long-term survival after hip trauma and surgery. Arch Gerontol Geriatr 60:431–436
Beloosesky Y, Grinblat J, Pirotsky A et al (2004) Different C-reactive protein kinetics in post-operative hip-fractured geriatric patients with and without complications. Gerontology 50:216–222
Gonzalez-Montalvo JI, Alarcon T, Mauleon JL et al (2010) The orthogeriatric unit for acute patients: a new model of care that improves efficiency in the management of patients with hip fracture. Hip Int 20:229–235
Adunsky A, Lusky A, Arad M et al (2003) A comparative study of rehabilitation outcomes of elderly hip fracture patients: the advantage of a comprehensive orthogeriatric approach. J Gerontol A Biol Sci Med Sci 58:542–547
Pedersen SJ, Borgbjerg FM, Schousboe B et al (2008) A comprehensive hip fracture program reduces complication rates and mortality. J Am Geriatr Soc 56:1831–1838
Stenqvist C, Madsen CM, Riis T et al (2016) Orthogeriatric service reduces mortality in patients with hip fracture. Geriatr Orthop Surg Rehabil 7:67–73
This research was supported by a Grant from Region Zealand.
Conflict of interest
Debbie Norring-Agerskov, Lise Bathum, Ole B. Pedersen, Bo Abrahamsen, Jes B. Lauritzen, Niklas R. Jørgensen, and Henrik L. Jørgensen declare that they have no conflict of interest.
Statement of human and animal rights
The human data are derived from registers and the data were anonymized prior to our use. Animals were not used in this study.
In this case, informed consent from the individual patients is not required according to Danish law.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Norring-Agerskov, D., Bathum, L., Pedersen, O.B. et al. Biochemical markers of inflammation are associated with increased mortality in hip fracture patients: the Bispebjerg Hip Fracture Biobank. Aging Clin Exp Res 31, 1727–1734 (2019). https://doi.org/10.1007/s40520-019-01140-7
- Hip fracture
- Inflammatory markers